Nuvation Bio Inc.
NUVB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $714,934 | $330,509 | $416,104 | $1,682,040 |
| - Cash | $35,723 | $42,649 | $101,099 | $132,423 |
| + Debt | $8,915 | $4,007 | $4,260 | $3,055 |
| Enterprise Value | $688,126 | $291,867 | $319,265 | $1,552,672 |
| Revenue | $7,873 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $795 | $0 | $0 | $0 |
| % Margin | 10.1% | – | – | – |
| EBITDA | -$566,915 | -$75,580 | -$119,535 | -$93,134 |
| % Margin | -7,200.7% | – | – | – |
| Net Income | -$567,939 | -$75,802 | -$104,199 | -$86,848 |
| % Margin | -7,213.8% | – | – | – |
| EPS Diluted | -2.11 | -0.35 | -0.48 | -0.44 |
| % Growth | -502.9% | 27.1% | -9.1% | – |
| Operating Cash Flow | -$130,413 | -$67,999 | -$96,108 | -$68,190 |
| Capital Expenditures | -$162 | -$69 | -$370 | -$282 |
| Free Cash Flow | -$130,575 | -$68,068 | -$96,478 | -$68,472 |